title: Rituximab and CHOP chemotherapy plus GM-CSF for previously untreated diffuse large B-cell lymphoma in the elderly: a Wisconsin oncology network study.
authors.affiliation: Department of Medicine, University of Wisconsin School of Medicine and Public Health and UW Carbone Cancer Center, Madison, WI, USA.
authors.forename: Julie E
authors.initials: JE
authors.lastname: Chang
authors.forename: Songwong
authors.initials: S
authors.lastname: Seo
authors.forename: Kyungmann M
authors.initials: KM
authors.lastname: Kim
authors.forename: Jae E
authors.initials: JE
authors.lastname: Werndli
authors.forename: Wayne A
authors.initials: WA
authors.lastname: Bottner
authors.forename: Gilberto A
authors.initials: GA
authors.lastname: Rodrigues
authors.forename: Federico A
authors.initials: FA
authors.lastname: Sanchez
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Saphner
authors.forename: Walter L
authors.initials: WL
authors.lastname: Longo
authors.forename: Brad S
authors.initials: BS
authors.lastname: Kahl
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D018572:Disease-Free Survival; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects; D004357:Drug Synergism; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects; D000069283:Rituximab; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D003520:Cyclophosphamide; D011241:Prednisone